192 related articles for article (PubMed ID: 21263056)
21. Aerosolized Bacillus anthracis infection in New Zealand white rabbits: natural history and intravenous levofloxacin treatment.
Yee SB; Hatkin JM; Dyer DN; Orr SA; Pitt ML
Comp Med; 2010 Dec; 60(6):461-8. PubMed ID: 21262133
[TBL] [Abstract][Full Text] [Related]
22. Next-Generation Bacillus anthracis Live Attenuated Spore Vaccine Based on the htrA(-) (High Temperature Requirement A) Sterne Strain.
Chitlaru T; Israeli M; Bar-Haim E; Elia U; Rotem S; Ehrlich S; Cohen O; Shafferman A
Sci Rep; 2016 Jan; 6():18908. PubMed ID: 26732659
[TBL] [Abstract][Full Text] [Related]
23. Determination of antibiotic efficacy against Bacillus anthracis in a mouse aerosol challenge model.
Heine HS; Bassett J; Miller L; Hartings JM; Ivins BE; Pitt ML; Fritz D; Norris SL; Byrne WR
Antimicrob Agents Chemother; 2007 Apr; 51(4):1373-9. PubMed ID: 17296745
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of ETI-204 monoclonal antibody as an adjunct therapy in a New Zealand white rabbit partial survival model for inhalational anthrax.
Biron B; Beck K; Dyer D; Mattix M; Twenhafel N; Nalca A
Antimicrob Agents Chemother; 2015 Apr; 59(4):2206-14. PubMed ID: 25645849
[TBL] [Abstract][Full Text] [Related]
25. Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.
Bielinska AU; Janczak KW; Landers JJ; Makidon P; Sower LE; Peterson JW; Baker JR
Infect Immun; 2007 Aug; 75(8):4020-9. PubMed ID: 17502384
[TBL] [Abstract][Full Text] [Related]
26. Protective antigen as a correlative marker for anthrax in animal models.
Kobiler D; Weiss S; Levy H; Fisher M; Mechaly A; Pass A; Altboum Z
Infect Immun; 2006 Oct; 74(10):5871-6. PubMed ID: 16988266
[TBL] [Abstract][Full Text] [Related]
27. A high-affinity monoclonal antibody to anthrax protective antigen passively protects rabbits before and after aerosolized Bacillus anthracis spore challenge.
Mohamed N; Clagett M; Li J; Jones S; Pincus S; D'Alia G; Nardone L; Babin M; Spitalny G; Casey L
Infect Immun; 2005 Feb; 73(2):795-802. PubMed ID: 15664918
[TBL] [Abstract][Full Text] [Related]
28. Treatment of anthrax infection with combination of ciprofloxacin and antibodies to protective antigen of Bacillus anthracis.
Karginov VA; Robinson TM; Riemenschneider J; Golding B; Kennedy M; Shiloach J; Alibek K
FEMS Immunol Med Microbiol; 2004 Jan; 40(1):71-4. PubMed ID: 14734189
[TBL] [Abstract][Full Text] [Related]
29. Progress towards the Development of a NEAT Vaccine for Anthrax II: Immunogen Specificity and Alum Effectiveness in an Inhalational Model.
Jelinski J; Terwilliger A; Green S; Maresso A
Infect Immun; 2020 Jul; 88(8):. PubMed ID: 32393506
[No Abstract] [Full Text] [Related]
30. Immunization with a Recombinant, Pseudomonas fluorescens-Expressed, Mutant Form of Bacillus anthracis-Derived Protective Antigen Protects Rabbits from Anthrax Infection.
Reed MD; Wilder JA; Mega WM; Hutt JA; Kuehl PJ; Valderas MW; Chew LL; Liang BC; Squires CH
PLoS One; 2015; 10(7):e0130952. PubMed ID: 26207820
[TBL] [Abstract][Full Text] [Related]
31. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.
Wimer-Mackin S; Hinchcliffe M; Petrie CR; Warwood SJ; Tino WT; Williams MS; Stenz JP; Cheff A; Richardson C
Vaccine; 2006 May; 24(18):3953-63. PubMed ID: 16530302
[TBL] [Abstract][Full Text] [Related]
32. BA3338, a surface layer homology domain possessing protein augments immune response and protection efficacy of protective antigen against Bacillus anthracis in mouse model.
Kumar M; Puranik N; Varshney A; Tripathi N; Pal V; Goel AK
J Appl Microbiol; 2020 Aug; 129(2):443-452. PubMed ID: 32118336
[TBL] [Abstract][Full Text] [Related]
33. The US capitol bioterrorism anthrax exposures: clinical epidemiological and immunological characteristics.
Doolan DL; Freilich DA; Brice GT; Burgess TH; Berzins MP; Bull RL; Graber NL; Dabbs JL; Shatney LL; Blazes DL; Bebris LM; Malone MF; Eisold JF; Mateczun AJ; Martin GJ
J Infect Dis; 2007 Jan; 195(2):174-84. PubMed ID: 17191162
[TBL] [Abstract][Full Text] [Related]
34. A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores.
Hermanson G; Whitlow V; Parker S; Tonsky K; Rusalov D; Ferrari M; Lalor P; Komai M; Mere R; Bell M; Brenneman K; Mateczun A; Evans T; Kaslow D; Galloway D; Hobart P
Proc Natl Acad Sci U S A; 2004 Sep; 101(37):13601-6. PubMed ID: 15342913
[TBL] [Abstract][Full Text] [Related]
35. [Immunogenicity of the recombinant Bacillus strains with cloned gene of biosynthesis of protective antigen against Bacillus anthracis].
Mikshis NI; Kudriavtseva OM; Bolothikova MF; Shulepov DV; Novikova LV; Popov IuA; Shchukovskaia TN; Drozdov IG; Kutyrev VV
Mol Gen Mikrobiol Virusol; 2007; (3):15-21. PubMed ID: 17886469
[TBL] [Abstract][Full Text] [Related]
36. A bivalent protein r-PB, comprising PA and BclA immunodominant regions for comprehensive protection against Bacillus anthracis.
Majumder S; Das S; Somani V; Makam SS; Joseph KJ; Bhatnagar R
Sci Rep; 2018 May; 8(1):7242. PubMed ID: 29740033
[TBL] [Abstract][Full Text] [Related]
37. Chimeric hepatitis B virus core particles carrying an epitope of anthrax protective antigen induce protective immunity against Bacillus anthracis.
Yin Y; Zhang J; Dong D; Liu S; Guo Q; Song X; Li G; Fu L; Xu J; Chen W
Vaccine; 2008 Oct; 26(46):5814-21. PubMed ID: 18786589
[TBL] [Abstract][Full Text] [Related]
38. A Bivalent Protein r-PAbxpB Comprising PA Domain IV and Exosporium Protein BxpB Confers Protection Against
Majumder S; Das S; Somani VK; Makam SS; Kingston JJ; Bhatnagar R
Front Immunol; 2019; 10():498. PubMed ID: 30941133
[TBL] [Abstract][Full Text] [Related]
39. Protection of farm goats by combinations of recombinant peptides and formalin inactivated spores from a lethal Bacillus anthracis challenge under field conditions.
Koehler SM; Buyuk F; Celebi O; Demiraslan H; Doganay M; Sahin M; Moehring J; Ndumnego OC; Otlu S; van Heerden H; Beyer W
BMC Vet Res; 2017 Jul; 13(1):220. PubMed ID: 28701192
[TBL] [Abstract][Full Text] [Related]
40. Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax.
Albrecht MT; Li H; Williamson ED; LeButt CS; Flick-Smith HC; Quinn CP; Westra H; Galloway D; Mateczun A; Goldman S; Groen H; Baillie LW
Infect Immun; 2007 Nov; 75(11):5425-33. PubMed ID: 17646360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
